{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:52:01Z","timestamp":1790506321204,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.annder.2015.07.015","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T14:23:43Z","timestamp":1461939823000},"page":"590-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pregnancy and contraception in systemic and cutaneous lupus erythematosus"],"prefix":"10.1016","volume":"143","author":[{"given":"G.","family":"Guettrot-Imbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Plu-bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Frances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2015.07.015_bib0360","doi-asserted-by":"crossref","first-page":"e104303","DOI":"10.1371\/journal.pone.0104303","article-title":"Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"9","author":"Rojas-Villarraga","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2015.07.015_bib0365","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/art.24398","article-title":"Combined oral contraceptive use and the risk of systemic lupus erythematosus","volume":"61","author":"Bernier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0370","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2015.07.015_bib0375","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2015.07.015_bib0380","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.annder.2015.07.015_bib0385","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","article-title":"Pregnaneprogestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients","volume":"83","author":"Chabbert-Buffet","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.annder.2015.07.015_bib0390","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/gme.0b013e3181e102eb","article-title":"Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen","volume":"17","author":"Canonico","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.annder.2015.07.015_bib0395","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.annder.2015.07.015_bib0400","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.revmed.2014.07.012","article-title":"[The prepregnancy counseling]","volume":"36","author":"Le Guern","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2015.07.015_bib0405","first-page":"CD001059","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"6","author":"Hofmeyr","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2015.07.015_bib0410","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","article-title":"Adherence to treatment in systemic lupus erythematosus patients","volume":"27","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0415","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetric outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rdc.2007.01.003","article-title":"The Hopkins Lupus Pregnancy Center: ten key issues in management","volume":"33","author":"Petri","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.annder.2015.07.015_bib0425","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000030","article-title":"Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature","volume":"26","author":"Peart","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0430","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0961203312456893","article-title":"Pregnancy and renal outcomes in lupus nephritis: an update and guide to management","volume":"21","author":"Bramham","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2015.07.015_bib0435","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.annder.2015.07.015_bib0440","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.annder.2015.07.015_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annder.2015.07.015_bib0450","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.revmed.2014.12.005","article-title":"[Systemic lupus erythematosus and antiphospholipid syndrome: how to manage pregnancy?]","volume":"36","author":"Guettrot-Imbert","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2015.07.015_bib0455","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3899\/jrheum.090872","article-title":"The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications","volume":"37","author":"Gladman","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0460","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.100997","article-title":"Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis","volume":"38","author":"Bramham","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0465","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0961203310397967","article-title":"Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus","volume":"20","author":"Kwok","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2015.07.015_bib0470","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2013.10.056","article-title":"Ten common mistakes in the management of lupus nephritis","volume":"63","author":"Bose","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0475","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","author":"Roberts","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2015.07.015_bib0480","first-page":"920467","article-title":"Aspirin for prevention of preeclampsia in lupus pregnancy","volume":"2014","author":"Schramm","year":"2014","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0485","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10067-012-1941-4","article-title":"Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy","volume":"31","author":"Saavedra","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0490","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203310394894","article-title":"Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery","volume":"20","author":"Stagnaro-Green","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2015.07.015_bib0495","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annder.2015.07.015_bib0500","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/annrheumdis-2011-201210","article-title":"Second pregnancy outcomes for women with systemic lupus erythematosus","volume":"72","author":"Shand","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0505","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/41.6.643","article-title":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies","volume":"41","author":"Cortes-Hernandez","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2015.07.015_bib0510","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2015.07.015_bib0515","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0520","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/14767058.2011.572310","article-title":"Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women","volume":"25","author":"Liu","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.annder.2015.07.015_bib0525","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/kei159","article-title":"The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and\/or the antiphospholipid syndrome","volume":"45","author":"Le Thi Huong","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2015.07.015_bib0530","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.revmed.2014.07.013","article-title":"[Neonatal lupus syndrome: literature review]","volume":"36","author":"Morel","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2015.07.015_bib0535","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro associated cardiac neonatal lupus","volume":"124","author":"Izmirly Peter","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.annder.2015.07.015_bib0540","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0368-2315(06)76388-8","article-title":"Prise en charge obst\u00e9tricale des patientes \u00e0 risque de \u00ab\u00a0lupus n\u00e9onatal\u00a0\u00bb","volume":"35","author":"Costedoat-Chalumeau","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.annder.2015.07.015_bib0545","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/art.20126","article-title":"Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA\/Ro 52-kd antibodies","volume":"50","author":"Sonesson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0550","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/hc0702.104182","article-title":"Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis","volume":"105","author":"Nield","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.annder.2015.07.015_bib0555","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.100317","article-title":"A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA\/Ro and anti-SSB\/La antibodies","volume":"38","author":"Guettrot-Imbert","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0560","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.annder.2015.07.015_bib0565","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0570","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0575","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0580","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.annder.2015.07.015_bib0585","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2011-200614","article-title":"Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called \u2018seronegative APS\u2019)","volume":"71","author":"Rodriguez-Garcia","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0590","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mob.2001.113846","article-title":"Antiphospholipid antibodies in women at risk for preeclampsia","volume":"184","author":"Branch","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annder.2015.07.015_bib0595","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le ThiThuong","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0600","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2012.01.003","article-title":"[Pregnancy and antiphospholipid syndrome]","volume":"33","author":"Costedoat-Chalumeau","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2015.07.015_bib0605","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ket167","article-title":"Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases","volume":"52","author":"Hanouna","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2015.07.015_bib0610","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cll.2013.01.003","article-title":"Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy","volume":"33","author":"Gomez-Puerta","year":"2013","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.annder.2015.07.015_bib0615","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.annder.2015.07.015_bib0620","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0625","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2015.07.015_bib0630","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2015.07.015_bib0635","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2014.02.003","article-title":"14th International congress on antiphospholipid antibodies task force report on obstetric antiphospholipid syndrome","volume":"13","author":"de Jesus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.annder.2015.07.015_bib0640","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2015.07.015_bib0645","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.annder.2015.07.015_bib0650","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1600-0897.2001.d01-13.x","article-title":"Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis","volume":"46","author":"Carmona","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.annder.2015.07.015_bib0655","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ken181","article-title":"Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers","volume":"47","author":"Erkan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2015.07.015_bib0660","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annder.2015.07.015_bib0665","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0961203312465782","article-title":"Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management","volume":"22","author":"Alijotas-Reig","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2015.07.015_bib0670","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.annder.2015.07.015_bib0675","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","article-title":"High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin","volume":"44","author":"Erkan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2015.07.015_bib0680","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2011.153817","article-title":"Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study","volume":"71","author":"Martinez-Zamora","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2015.07.015_bib0685","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.jp.7211208","article-title":"Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation","volume":"25","author":"Motta","year":"2005","journal-title":"J Perinatol"},{"key":"10.1016\/j.annder.2015.07.015_bib0690","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"Ostensen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.annder.2015.07.015_bib0695","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/aogs.12158","article-title":"Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study","volume":"92","author":"Hamed","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annder.2015.07.015_bib0700","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2012.08.019","article-title":"Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)","volume":"12","author":"Biazar","year":"2013","journal-title":"Autoimmun Rev"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381600154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381600154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:03:56Z","timestamp":1758971036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S015196381600154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S015196381600154X"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2015.07.015","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy and contraception in systemic and cutaneous lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}